| REVOLUTION MEDICINES |
| USA |
| Gesundheit |
| US76155X1000 / A2PYWG |
| 42Z (Frankfurt) / RVMD (NASDAQ) |
| FRA:42Z, ETR:42Z, 42Z:GR, NASDAQ:RVMD |
| - |
| https://www.revmed.com/ |
|
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing targeted therapies for RAS-addicted cancers. The company applies proprietary drug discovery capabilities to create small-molecule medicines designed to ac..
>Volltext.. |
| 36311.31 Mio. EUR |
| 33903.28 Mio. EUR |
| - |
| -1436.63 Mio. EUR |
| -1578.68 Mio. EUR |
| -7.87 EUR |
| 1062.82 Mio. EUR |
| 728 Mio. EUR |
| -1091.89 Mio. EUR |
| 11.12 |
| - |
| -124.6% |
| - |
| - |
| - |
| 8 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 29.577.276 Euro. |
| REVOLUTION MEDICINES, REVOLUTION MED |
| 12.10.26 |
|
||||
|